MADRIGAL PHARMACEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Madrigal Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
  • Madrigal Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$152M, a 77.1% decline year-over-year.
  • Madrigal Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$510M, a 54.8% decline year-over-year.
  • Madrigal Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$374M, a 26.5% decline from 2022.
  • Madrigal Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$295M, a 22.1% decline from 2021.
  • Madrigal Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$242M, a 19.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$374M -$78.3M -26.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$295M -$53.5M -22.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$242M -$39.6M -19.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$202M -$118M -141% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-03-03
2019 -$83.9M -$51.1M -156% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$32.8M -$1.66M -5.32% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$31.2M -$4.77M -18.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$26.4M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.